Effect of warming Yang and removing blood stasis method on matrix metalloproteinases/tissue inhibitor metalloproteinases levels secreted by cultured endometrial cells from patients with endometriosis

被引:0
|
作者
Huang Yanhui [1 ,2 ,4 ]
Shen Lin [2 ]
Cai Anhe [3 ]
Xiao Jing [4 ]
机构
[1] Wuhan Hosp Tradit Chinese Med, Dept Gynecol, Wuhan 430010, Peoples R China
[2] Huazhong Univ Sci & Technol, Wuhan Union Hosp, Tongji Med Coll, Dept Tradit Chinese Med, Wuhan 430022, Peoples R China
[3] Guangdong Prov Hosp Chinese Med, Dept Gastroenterol, Guangzhou 510120, Guangdong, Peoples R China
[4] Guangdong Prov Hosp Chinese Med, Dept Gynecol, Guangzhou 510120, Guangdong, Peoples R China
关键词
Endometriosis; Matrix metalloproteinases; Tissue inhibitor of metalloproteinases; Warming Yang; Removing blood stasis; TISSUE INHIBITOR; EUTOPIC ENDOMETRIUM; PROMOTER REGIONS; EXPRESSION; POLYMORPHISMS; ANGIOGENESIS; ADENOMYOSIS; SUPPRESSION; PERITONEAL; OVARIAN;
D O I
暂无
中图分类号
R [医药、卫生];
学科分类号
10 ;
摘要
OBJECTIVE: To investigate the effect of Chinese medicines using the warming Yang and removing blood stasis method on levels of matrix metalloproteinases (MMPs)/tissue inhibitor metalloproteinases (TIMPs) secreted by cultured endometrial cells from patients with endometriosis. METHODS: Ectopic and eutopic endometrial cells obtaind from 15 endometriosis patients were cultured in vitro, and divided randomly into five groups: high dose; moderate dose; low dose; nemestran; blank control. The three dose groups were treated with a decoction prepared according to the principle of warming Yang and removing blood stasis; nemestran and 0.9% NaCl were administered to the nemestran group and balnk control group, respectively. Eutopic endometrial cells obtaind from 10 hysteromyoma patients were cultured in vitro,as the normal control group,0.9% NaCI were administered to the normal control group. Cell culture supernatants were collected and levels of matrix metalloproteinase-1 (MMP-1), matrix metalloproteinase-2 (MMP-2), matrix metalloproteinase-9 (MMP-9), tissue inhibitor metalloproteinase-1 (TIMP-1) and tissue inhibitor metalloproteinase -2 (TIMP-2) detected by enzyme-linked immuno sorbent assay (ELISA). RESULTS: Compared with the normal control group, levels of MMP-1, MMP-2, and MMP-9 in eutopic and ectopic endometrium cell supernatants in the blank control group were increased, whereas levels of TIMP-1 and TIMP-2 were decreased (P < 0.05). Compared with the blank control group, levels of MMP-1 and MMP-2 in ectopic and eutopic endometrium cell supernatants cultured in low-dose, middle-dose, and high-dose groups were decreased, whereas levels of TIMP-1 and TIMP-2 were increased significantly (P < 0.05). CONCLUSION: The warming Yang and removing blood stasis method affects expression of MMPs and TIMPs. (C) 2015 JTCM. All rights reserved.
引用
收藏
页码:571 / 576
页数:6
相关论文
共 9 条
  • [1] Effect of warming Yang and removing blood stasis method on matrix metalloproteinases/tissue inhibitor metalloproteinases levels secreted by cultured endometrial cells from patients with endometriosis
    Huang Yanhui
    Shen Lin
    Cai Anhe
    Xiao Jing
    JournalofTraditionalChineseMedicine, 2015, 35 (05) : 571 - 576
  • [2] Tissue inhibitor of matrix metalloproteinases 2 (TIMP-2) mRNA is upregulated by promegestone in endometrial cells from endometriosis patients.
    Sillem, M
    Prifti, S
    Neher, M
    Runnebaum, B
    FERTILITY AND STERILITY, 1997, : O120 - O120
  • [3] Comparison of levels of matrix metalloproteinases, tissue inhibitor of metalloproteinases, interleukins, and tissue necrosis factor in carotid endarterectomy specimens from patients on versus not on statins preoperatively
    Molloy, KJ
    Thompson, MM
    Schwalbe, EC
    Bell, PRF
    Naylor, AR
    Loftus, IM
    AMERICAN JOURNAL OF CARDIOLOGY, 2004, 94 (01): : 144 - 146
  • [4] Matrix Metalloproteinase-1 and Tissue Inhibitor of Metalloproteinases-1 Levels in Severely Obese Patients: What is the Effect of Weight Loss?
    Papazoglou, D.
    Papatheodorou, K.
    Papanas, N.
    Papadopoulos, T.
    Gioka, T.
    Kabouromiti, G.
    Kotsiou, S.
    Maltezos, E.
    EXPERIMENTAL AND CLINICAL ENDOCRINOLOGY & DIABETES, 2010, 118 (10) : 730 - 734
  • [5] Effects of Interferon-Tau (IFN-τ) and Progesterone on Transcription Level of Matrix Metalloproteinases-2 (MMP-2) and Tissue Inhibitor of Metalloproteinases-2 (TIMP-2) in Cultured Bovine Endometrial Cells
    Yao, Jia
    Zhang, Ming
    Feng, Yu-Mei
    Chen, Si-Yi
    Wang, Wei
    Wang, Jie
    Lai, Song-Jia
    JOURNAL OF ANIMAL AND VETERINARY ADVANCES, 2011, 10 (14): : 1833 - 1840
  • [6] Effect of interleukin-10 and platelet-derived growth factor on expressions of matrix metalloproteinases-2 and tissue inhibitor of metalloproteinases-1 in rat fibrotic liver and cultured hepatic stellate cells
    Zhang, Li-Juan
    Chen, Yun-Xin
    Chen, Zhi-Xin
    Huang, Yue-Hong
    Yu, Jie-ping
    Wang, Xiao-Zhong
    WORLD JOURNAL OF GASTROENTEROLOGY, 2004, 10 (17) : 2574 - 2579
  • [7] Effect of interleukin-10 and platelet-derived growth factor on expressions of matrix metalloproteinases-2 and tissue inhibitor of metalloproteinases-1 in rat fibrotic liver and cultured hepatic stellate cells
    Li-Juan Zhang Yun-Xin Chen Zhi-Xin Chen Yue-Hong Huang Jie-Ping Yu Xiao-Zhong Wang Department of Gastroenterology
    World Journal of Gastroenterology, 2004, (17) : 2574 - 2579
  • [8] IL-18 initiates release of matrix metalloproteinase-9 from peripheral blood mononuclear cells without affecting tissue inhibitor of matrix metalloproteinases-1: suppression by TNFα blockage and modulation by IL-10
    Marcel Nold
    Andreas Goede
    Wolfgang Eberhardt
    Josef Pfeilschifter
    Heiko Mühl
    Naunyn-Schmiedeberg's Archives of Pharmacology, 2003, 367 : 68 - 75
  • [9] IL-18 initiates release of matrix metalloproteinase-9 from peripheral blood mononuclear cells without affecting tissue inhibitor of matrix metalloproteinases-1:: suppression by TNFα blockage and modulation by IL-10
    Nold, M
    Goede, A
    Eberhardt, W
    Pfeilschifter, J
    Mühl, H
    NAUNYN-SCHMIEDEBERGS ARCHIVES OF PHARMACOLOGY, 2003, 367 (01) : 68 - 75